Voronoi Inc.

12 patents currently held · Updated Nov 15, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Mar 2040

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 15, 2027.

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 11,466,000	Heteroaryl Derivative, Method for Producing Same, and Pharmaceutical Composition Comprising Same as Effective Component In force Term ends Mar 19, 2040 · High confidence	In force	Term ends Mar 19, 2040	High confidence
US 12,157,730	Heteroaryl Derivative, Method for Producing Same, and Pharmaceutical Composition Comprising Same as Effective Component In force Term ends Mar 19, 2040 · High confidence	In force	Term ends Mar 19, 2040	High confidence
US 12,152,021	Heteroaryl Derivative, Method for Producing Same, and Pharmaceutical Composition Comprising Same as Effective Component In force Term ends Oct 29, 2041 · High confidence	In force	Term ends Oct 29, 2041	High confidence
US 12,194,048	Novel Use of Pyrrolopyridine Derivatives for Preventing or Treating Inflammatory Diseases In force Term ends Dec 9, 2041 · High confidence	In force	Term ends Dec 9, 2041	High confidence
US 12,157,741	Macrocyclic Inhibitors of DYRK1A In force Term ends Dec 11, 2041 · High confidence	In force	Term ends Dec 11, 2041	High confidence
US 12,240,844	Pyrrolopyridine Derivative and Use Thereof in Prevention and Treatment of Protein Kinase-Related Disease In force Term ends Mar 21, 2042 · High confidence	In force	Term ends Mar 21, 2042	High confidence
US 12,275,731	Azaindole Inhibitors of Wild-Type and Mutant Forms of LRRK2 In force Term ends Apr 21, 2042 · High confidence	In force	Term ends Apr 21, 2042	High confidence
US 12,528,799	Heteroaryl Derivative Compounds, and Uses Thereof In force Term ends May 16, 2042 · High confidence	In force	Term ends May 16, 2042	High confidence
US 12,534,457	Heteroaryl Derivative Compounds, and Uses Thereof In force Ends no later than May 16, 2042 · Medium confidence	In force	Ends no later than May 16, 2042	Medium confidence
US 12,037,330	Heteroaryl Derivative Compounds, and Uses Thereof In force Term ends Jun 27, 2042 · High confidence	In force	Term ends Jun 27, 2042	High confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Also on record, not counted in the 12: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 4 abandoned · 5 no status recorded

List them